Related Experiment Video
Updated: Mar 30, 2026

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
Dose-dependent difference of nuclear receptors involved in murine liver hypertrophy by piperonyl butoxide
Yohei Sakamoto1, Midori Yoshida, Kei Tamura
1Division of Pathology, National Institute of Health Sciences.
Abstract:
Nuclear receptors play important roles in chemically induced liver hypertrophy in rodents. To clarify the involvement of constitutive androstane receptor (CAR) and other nuclear receptors in mouse liver hypertrophy induced by different doses of piperonyl butoxide (PBO), wild-type and CAR-knockout mice were administered PBO (200, 1,000, or 5,000 ppm) in the basal diet for 1 week. Increased liver weight and diffuse hepatocellular hypertrophy were observed at 5,000 ppm for both genotypes, accompanied by increased Cyp3a11 mRNA and CYP3A protein expression, suggesting that CAR-independent pathway, possibly pregnane X receptor (PXR), plays a major role in the induction of hypertrophy. Moreover, wild-type mice at 5,000 ppm showed enhanced hepatocellular hypertrophy and strong positive staining for CYP2B in the centrilobular area, suggesting the localized contribution of CAR. At 1,000 ppm, only wild-type mice showed liver weight increase and centrilobular hepatocellular hypertrophy concurrent with elevated Cyp2b10 mRNA expression and strong CYP2B staining, indicating that CAR was essential at 1,000 ppm. We concluded that high-dose PBO induced hypertrophy via CAR and another pathway, while lower dose of PBO induced a pathway mediated predominantly by CAR. The dose-responsiveness on liver hypertrophy is important for understanding the involvement of nuclear receptors.
Insights
High doses of piperonyl butoxide (PBO) induce liver hypertrophy through constitutive androstane receptor (CAR)-independent and -dependent pathways. Lower PBO doses primarily rely on CAR for liver changes.
Area of Science:
- Toxicology
- Molecular Biology
- Pharmacology
Background:
- Nuclear receptors are critical regulators of chemical-induced liver hypertrophy in rodents.
- Constitutive androstane receptor (CAR) is a key nuclear receptor involved in xenobiotic metabolism and liver adaptation.
Purpose of the Study:
- To investigate the role of CAR and other nuclear receptors in mouse liver hypertrophy induced by varying doses of piperonyl butoxide (PBO).
- To elucidate the dose-dependent mechanisms of PBO-induced liver hypertrophy and the involvement of nuclear receptors.
Main Methods:
- Administration of PBO (200, 1,000, or 5,000 ppm) to wild-type and CAR-knockout mice for one week.
- Assessment of liver weight, hepatocellular hypertrophy, and expression of key genes (Cyp3a11, Cyp2b10) and proteins (CYP3A, CYP2B).
Main Results:
- High-dose PBO (5,000 ppm) caused liver hypertrophy in both wild-type and CAR-knockout mice, with increased Cyp3a11 mRNA and CYP3A protein, suggesting a CAR-independent pathway (possibly PXR).
- Wild-type mice at 5,000 ppm showed enhanced hypertrophy and CYP2B staining, indicating a localized CAR contribution.
- Lower PBO dose (1,000 ppm) induced liver weight increase and hypertrophy predominantly in wild-type mice, with elevated Cyp2b10 mRNA and CYP2B staining, highlighting CAR's essential role.
Conclusions:
- PBO-induced liver hypertrophy exhibits dose-dependent effects on nuclear receptor involvement.
- High-dose PBO triggers both CAR-dependent and -independent pathways, while lower doses primarily activate CAR-mediated responses.
- Understanding the dose-response relationship is crucial for deciphering the role of nuclear receptors in chemical-induced liver hypertrophy.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Signal Transduction: Overview
Typically, signal transduction involves three...
Regulation of Nuclear Protein Sorting

